Floatz logo

Therapeutic Asset Ratings

91,565 assets7,904 sponsors3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
Busulfanum
Burkitt Lymphoma
M.D. Anderson Cancer CenterP2BB (69)
Busulfanum
Peripheral T-Cell Lymphoma, Not Otherwise Specified
Xianmin Song, MDP2BB (69)
Busulfanum
Lymphoblastic Lymphoma
Masonic Cancer Center, University of MinnesotaP2BB (69)
Carboplatin
Gastric Cancer
Qilu Pharmaceutical Co., Ltd.P2BB (69)
Carboplatin
Pancreatic Neoplasm
Jinling Hospital, ChinaP2BB (69)
Carboplatin
Pancreatic Ductal Adenocarcinoma
AkesoP2BB (69)
Carboplatin
Renal Cell Carcinoma
Shanghai Henlius BiotechP2BB (69)
Cladribine
Acute Biphenotypic Leukemia
University of WashingtonP2BB (69)
Cladribine
Therapy Related Acute Myeloid Leukemia And Myelodysplastic Syndrome
University of Michigan Rogel Cancer CenterP2BB (69)
Cyclophosphamide
Amyloidosis
University of Alabama at BirminghamP2BB (69)
Cyclophosphamide
Precancerous Condition
Institut Paoli-CalmettesP2BB (69)
Cyclosporin A
Precancerous Condition
Institut Paoli-CalmettesP2BB (69)
Daratumumab
Acute Myeloid Leukemia
City of Hope Medical CenterP2BB (69)
Darolutamide
Breast Cancer
Vandana AbramsonP2BB (69)
Diphenhydramine
Acute Lymphoblastic Leukemia
PersonGen BioTherapeutics (Suzhou) Co., Ltd.P2BB (69)
Diphenhydramine
Hematopoietic And Lymphoid System Neoplasm
City of Hope Medical CenterP2BB (69)
Diphenhydramine
Myelodysplastic Syndrome
M.D. Anderson Cancer CenterP2BB (69)
Diphenhydramine
Neoplasm
Hellenic Society of HematologyP2BB (69)
Docetaxel
Squamous Cell Carcinoma
Hummingbird BioscienceP2BB (69)
Emestedastat
Cognitive Disorder
Actinogen MedicalP2BB (69)
Eribulin
Cancer
GI Innovation, Inc.P2BB (69)
Everolimus
Epilepsy
Xuanwu Hospital, BeijingP2BB (69)
Everolimus
Non-Small Cell Lung Carcinoma
Jiangsu Simcere Pharmaceutical Co., Ltd.P2BB (69)
Favezelimab
Hodgkins Lymphoma
Merck Sharp & Dohme LLCP2BB (69)
Fludarabine
Gastric Cancer
Vall d'Hebron Institute of OncologyP2BB (69)
Showing 3176 to 3200 of 42,285 assets
PreviousPage 128 of 1692Next